Jean Marshall

Last updated

Jean Sylvia Marshall, born in Birmingham, England, is a Canadian immunologist and acting Professor and Head of the Department of Microbiology & Immunology at Dalhousie University in Halifax, Nova Scotia, Canada. [1] Marshall's work has investigated how mast cells are involved in the early immune response to infection and antigen. She is best known for her discovery of the previously unknown degranulation-independent immunoregulatory roles of mast cells in infection and allergy and their ability to mobilize dendritic cells. [2]

Contents

Marshall's current research relates to studying innate immunity and local immune events and environment. Her work spans many fields, including immunology, inflammation, allergy, mast cell biology, chronic inflammatory disease, innate immunity, and cancer biology (specifically breast cancer). her lab also has a special interest in toll-like receptors in mucosal immune regulation.

Biography

Marshall attended high school in Loughborough, England and then completed a Bachelor of Science (Hons.) in Biochemistry at the University of Manchester in 1980. She then received a PhD in immunology from Manchester, investigating regulation of IgE and the generation of autoantibodies to it in 1983. [1] Her PhD supervisor was Eric Bell, the first to describe CD45 expression on memory T cells. [3] After her PhD, she completed postdoctoral fellowships at the University of Manchester and at McMaster University in Hamilton, Ontario, Canada under the supervision of John Bienenstock, one of the fathers of mucosal immunology. [4]

She was appointed assistant professor in the Department of Pathology at McMaster University in 1989, and associate professor in 1993. She then moved to the position of associate professor in the Departments of Microbiology & Immunology and Pathology at Dalhousie University in 1997, and became Full Professor in 1999. In 2005, she became the Head of the Department of Microbiology & Immunology. [1]

Research interests

Marshall has had a continued interest in mast cell biology and how it relates to many fields including Immunology, Allergy, Inflammation, Cancer, as well as others. Through her PhD she studied the regulation of IgE and how it coordinates immune responses, largely through interacting with receptors on mast cells.

Later in her career she studied mast cells more directly, characterizing their functions and receptors, in particularly in the context of virus infection. She determined that mast cells are involved in the response to viruses, and was the first to describe their specific response to Dengue virus infection. [5] She then went on to further characterize mast cells and their surface receptors, including TLR2 which she discovered was critical for mast cell signalling during the response to cancer. [6] One of her discoveries relates to the degranulation-independent roles of mast cells and their ability to mobilize dendritic cells during the early immune response to infection or antigen. [2]

Her early work characterizing the role of the histamine receptor on mast cells has now become relevant to the context of cancer. She has completed murine studies looking at how over the counter Histamine 2 receptor antagonists, such as Ranitidine, can slow or reduce the growth of tumors such as those in breast cancer. [7]

Awards

Leadership

Highest impact publications after 2000

  1. J.S. Marshall.  Mast cell responses to pathogens.  Nature Reviews Immunology. 4:787-799 (2004) Cited 864 timesaccordingto GoogleScholar [10]
  2. McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. Journal of Immunology. 2003 Feb 15;170(4):1625-9. Cited 404 times according to Google Scholar [10]
  3. Dawicki W, Marshall JS. New and emerging roles for mast cells in host defence. Current opinion in immunology. 2007 Feb 1;19(1):31-8. Cited 307 times according to Google Scholar [10]
  4. McCurdy JD, Lin TJ, Marshall JS. Toll‐like receptor 4‐mediated activation of murine mast cells. Journal of leukocyte biology. 2001 Dec;70(6):977-84. Cited 235 times according to Google Scholar [10]
  5. Marshall JS, Jawdat DM. Mast cells in innate immunity. Journal of allergy and clinical immunology. 2004 Jul 1;114(1):21-7. Cited 230 times according to Google Scholar [10]

Related Research Articles

<span class="mw-page-title-main">Antigen</span> Molecule triggering an immune response (antibody production) in the host

In immunology, an antigen (Ag) is a molecule, moiety, foreign particulate matter, or an allergen, such as pollen, that can bind to a specific antibody or T-cell receptor. The presence of antigens in the body may trigger an immune response.

<span class="mw-page-title-main">Immune system</span> Biological system protecting an organism against disease

The immune system is a network of biological systems that protects an organism from diseases. It detects and responds to a wide variety of pathogens, from viruses to parasitic worms, as well as cancer cells and objects such as wood splinters, distinguishing them from the organism's own healthy tissue. Many species have two major subsystems of the immune system. The innate immune system provides a preconfigured response to broad groups of situations and stimuli. The adaptive immune system provides a tailored response to each stimulus by learning to recognize molecules it has previously encountered. Both use molecules and cells to perform their functions.

<span class="mw-page-title-main">Immunology</span> Branch of medicine studying the immune system

Immunology is a branch of biology and medicine that covers the study of immune systems in all organisms.

<span class="mw-page-title-main">Autoimmunity</span> Immune response against an organisms own healthy cells

In immunology, autoimmunity is the system of immune responses of an organism against its own healthy cells, tissues and other normal body constituents. Any disease resulting from this type of immune response is termed an "autoimmune disease". Prominent examples include celiac disease, diabetes mellitus type 1, Henoch–Schönlein purpura, systemic lupus erythematosus, Sjögren syndrome, eosinophilic granulomatosis with polyangiitis, Hashimoto's thyroiditis, Graves' disease, idiopathic thrombocytopenic purpura, Addison's disease, rheumatoid arthritis, ankylosing spondylitis, polymyositis, dermatomyositis, and multiple sclerosis. Autoimmune diseases are very often treated with steroids.

An immune response is a physiological reaction which occurs within an organism in the context of inflammation for the purpose of defending against exogenous factors. These include a wide variety of different toxins, viruses, intra- and extracellular bacteria, protozoa, helminths, and fungi which could cause serious problems to the health of the host organism if not cleared from the body.

<span class="mw-page-title-main">Natural killer cell</span> Type of cytotoxic lymphocyte

Natural killer cells, also known as NK cells, are a type of cytotoxic lymphocyte critical to the innate immune system. They are a kind of large granular lymphocytes (LGL), and belong to the rapidly expanding family of known innate lymphoid cells (ILC) and represent 5–20% of all circulating lymphocytes in humans. The role of NK cells is analogous to that of cytotoxic T cells in the vertebrate adaptive immune response. NK cells provide rapid responses to virus-infected cells, stressed cells, tumor cells, and other intracellular pathogens based on signals from several activating and inhibitory receptors. Most immune cells detect the antigen presented on major histocompatibility complex I (MHC-I) on infected cell surfaces, but NK cells can recognize and kill stressed cells in the absence of antibodies and MHC, allowing for a much faster immune reaction. They were named "natural killers" because of the notion that they do not require activation to kill cells that are missing "self" markers of MHC class I. This role is especially important because harmful cells that are missing MHC I markers cannot be detected and destroyed by other immune cells, such as T lymphocyte cells.

<span class="mw-page-title-main">Immunoglobulin E</span> Immunoglobulin E (IgE) Antibody

Immunoglobulin E (IgE) is a type of antibody that has been found only in mammals. IgE is synthesised by plasma cells. Monomers of IgE consist of two heavy chains and two light chains, with the ε chain containing four Ig-like constant domains (Cε1–Cε4). IgE is thought to be an important part of the immune response against infection by certain parasitic worms, including Schistosoma mansoni, Trichinella spiralis, and Fasciola hepatica. IgE is also utilized during immune defense against certain protozoan parasites such as Plasmodium falciparum. IgE may have evolved as a defense to protect against venoms.

<span class="mw-page-title-main">Polly Matzinger</span> French-born American immunologist

Polly Celine Eveline Matzinger is a French-born immunologist who proposed the danger model theory of how the immune system works.

Memory T cells are a subset of T lymphocytes that might have some of the same functions as memory B cells. Their lineage is unclear.

<span class="mw-page-title-main">Ellen Heber-Katz</span>

Ellen Heber-Katz is an American immunologist and regeneration biologist who works as a professor at Lankenau Institute for Medical Research (LIMR). She discovered that the Murphy Roths Large (MRL) mouse strain can regenerate wounds without scarring and fully restore damaged tissue. Her research focuses on immunology, regenerative medicine, and cancer. In July 2015, she expanded her research to include studies funded by the National Cancer Institute (NCI) that investigate novel aspects of breast cancer causation.

<span class="mw-page-title-main">Toll-like receptor 6</span> Protein found in humans

Toll-like receptor 6 is a protein that in humans is encoded by the TLR6 gene. TLR6 is a transmembrane protein, member of toll-like receptor family, which belongs to the pattern recognition receptor (PRR) family. TLR6 acts in a heterodimer form with toll-like receptor 2 (TLR2). Its ligands include multiple diacyl lipopeptides derived from gram-positive bacteria and mycoplasma and several fungal cell wall saccharides. After dimerizing with TLR2, the NF-κB intracellular signalling pathway is activated, leading to a pro-inflammatory cytokine production and activation of innate immune response. TLR6 has also been designated as CD286.

Gamma delta T cells are T cells that have a γδ T-cell receptor (TCR) on their surface. Most T cells are αβ T cells with TCR composed of two glycoprotein chains called α (alpha) and β (beta) TCR chains. In contrast, γδ T cells have a TCR that is made up of one γ (gamma) chain and one δ (delta) chain. This group of T cells is usually less common than αβ T cells. Their highest abundance is in the gut mucosa, within a population of lymphocytes known as intraepithelial lymphocytes (IELs).

<span class="mw-page-title-main">HAVCR2</span> Protein-coding gene in the species Homo sapiens

Hepatitis A virus cellular receptor 2 (HAVCR2), also known as T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), is a protein that in humans is encoded by the HAVCR2 (TIM-3)gene. HAVCR2 was first described in 2002 as a cell surface molecule expressed on IFNγ producing CD4+ Th1 and CD8+ Tc1 cells. Later, the expression was detected in Th17 cells, regulatory T-cells, and innate immune cells. HAVCR2 receptor is a regulator of the immune response.

The following outline is provided as an overview of and topical guide to immunology:

Immunology is the study of the immune system during health and disease. Below is a list of immunology-related articles.

<span class="mw-page-title-main">Akiko Iwasaki</span> Immunobiologist

Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19, and long COVID.

<span class="mw-page-title-main">Intestinal mucosal barrier</span>

The intestinal mucosal barrier, also referred to as intestinal barrier, refers to the property of the intestinal mucosa that ensures adequate containment of undesirable luminal contents within the intestine while preserving the ability to absorb nutrients. The separation it provides between the body and the gut prevents the uncontrolled translocation of luminal contents into the body proper. Its role in protecting the mucosal tissues and circulatory system from exposure to pro-inflammatory molecules, such as microorganisms, toxins, and antigens is vital for the maintenance of health and well-being. Intestinal mucosal barrier dysfunction has been implicated in numerous health conditions such as: food allergies, microbial infections, irritable bowel syndrome, inflammatory bowel disease, celiac disease, metabolic syndrome, non-alcoholic fatty liver disease, diabetes, and septic shock.

An innate immune defect is a defect in the innate immune response that blunts the response to infection. These defects may occur in monocytes, neutrophils, natural killer cells, basophils, mast cells or complement proteins.

Carol Shoshkes Reiss, an American viral immunologist, was a professor at New York University's Department of Biology between 1991 and 2020. She is currently a professor emerita at New York University. Her research focused on the dynamic contest between the mouse immune system and virus replication during central nervous system infection. Reiss was editor-in-chief of the journal Viral Immunology (2000–2006) and is currently editor-in-chief of the journal DNA and Cell Biology (2012–present).

<span class="mw-page-title-main">Carla V. Rothlin</span> Argentinian immunologist

Carla V. Rothlin is an Argentinian immunologist. She is a professor of immunobiology at Yale University, where she holds the Dorys McConnell Duberg Professorship, and also serves as a professor of pharmacology. Rothlin is the co-leader of the Cancer Immunology Program at Yale Cancer Center and a Howard Hughes Medical Investigator Faculty Scholar.

References

  1. 1 2 3 "Jean Marshall". Dalhousie University. Retrieved 2019-03-26.
  2. 1 2 Marshall, Jean S.; Rowden, Geoffrey; Jawdat, Dunia M. (2006-08-01). "Mast Cells Have a Pivotal Role in TNF-Independent Lymph Node Hypertrophy and the Mobilization of Langerhans Cells in Response to Bacterial Peptidoglycan". The Journal of Immunology. 177 (3): 1755–1762. doi: 10.4049/jimmunol.177.3.1755 . ISSN   0022-1767. PMID   16849485.
  3. ↑ Bunce, Campbell; Bell, Eric B. (1997-02-17). "CD45RC Isoforms Define Two Types of CD4 Memory T Cells, One of which Depends on Persisting Antigen". The Journal of Experimental Medicine. 185 (4): 767–776. doi:10.1084/jem.185.4.767. ISSN   0022-1007. PMC   2196145 . PMID   9034154.
  4. ↑ "Dr. John Bienenstock | Canadian Medical Hall of Fame". 2014-08-19. Archived from the original on 2014-08-19. Retrieved 2019-03-26.
  5. ↑ King, Christine A.; Anderson, Robert; Marshall, Jean S. (August 2002). "Dengue Virus Selectively Induces Human Mast Cell Chemokine Production". Journal of Virology. 76 (16): 8408–8419. doi:10.1128/JVI.76.16.8408-8419.2002. ISSN   0022-538X. PMC   155122 . PMID   12134044.
  6. ↑ Marshall, Jean S.; Johnston, Brent; Leiva, Carlos A.; Howatt, Mackenzie A.; Haidl, Ian D.; Oldford, Sharon A. (2010-12-01). "A Critical Role for Mast Cells and Mast Cell-Derived IL-6 in TLR2-Mediated Inhibition of Tumor Growth". The Journal of Immunology. 185 (11): 7067–7076. doi: 10.4049/jimmunol.1001137 . ISSN   0022-1767. PMID   21041732.
  7. ↑ Rogers, Dakota; Vila-Leahey, Ava; Pessôa, Ana Clara; Oldford, Sharon; Marignani, Paola A.; Marshall, Jean S. (2018-08-15). "Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response". Frontiers in Immunology. 9: 1894. doi: 10.3389/fimmu.2018.01894 . ISSN   1664-3224. PMC   6104125 . PMID   30158936.
  8. ↑ "Dal researcher wins Canada's top immunology award". Dalhousie News. Retrieved 2019-03-26.
  9. ↑ "Research Management Committee – AllerGen". Archived from the original on 2019-03-27. Retrieved 2019-03-26.
  10. 1 2 3 4 5 "User profiles for JS Marsha". Google Scholar. Retrieved January 19, 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.